A detailed history of Strategic Advocates LLC transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Strategic Advocates LLC holds 36 shares of A stock, worth $5,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36
Holding current value
$5,285
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 26, 2025

BUY
$112.04 - $128.75 $4,033 - $4,635
36 New
36 $4.62 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $43.5B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Strategic Advocates LLC Portfolio

Follow Strategic Advocates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advocates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advocates LLC with notifications on news.